Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China
· Delayed Price · Currency is CNY 5.86
-0.32 (-5.18%)
Apr 29, 2026, 3:00 PM CST
SHA:600488 Revenue
Tianjin Tianyao Pharmaceuticals had revenue of 608.11M CNY in the quarter ending March 31, 2026, a decrease of -22.61%. This brings the company's revenue in the last twelve months to 2.73B, down -12.97% year-over-year. In the year 2025, Tianjin Tianyao Pharmaceuticals had annual revenue of 2.91B, down -9.56%.
Revenue (ttm)
2.73B
Revenue Growth
-12.97%
P/S Ratio
2.34
Revenue / Employee
946.73K
Employees
2,884
Market Cap
6.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.91B | -307.25M | -9.56% |
| Dec 31, 2024 | 3.22B | -567.54M | -15.00% |
| Dec 31, 2023 | 3.78B | 93.90M | 2.55% |
| Dec 31, 2022 | 3.69B | -59.73M | -1.59% |
| Dec 31, 2021 | 3.75B | 631.82M | 20.27% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Haiyao | 831.18M |
| Guizhou Bailing Group Pharmaceutical | 3.15B |
| Shandong Wit Dyne Health | 2.02B |
| Cisen Pharmaceutical | 3.44B |
| Beijing Sun-Novo Pharmaceutical Research | 1.19B |
| Hunan Jiudian Pharmaceutical | 3.01B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Beijing SL Pharmaceutical | 578.61M |